China Longyuan Power Group Corporation Limited (HKG:0916)

Revance Therapeutics Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	113,027	105,659	129,748	136,001	146,262	62,443
Market Cap Growth	-8.36%	-18.57%	-4.60%	-7.02%	134.23%	57.61%
Enterprise Value	265,051	239,770	242,934	251,681	262,258	162,535
PE Ratio	10.55	15.57	18.83	24.54	16.60	11.13
PS Ratio	3.58	3.17	3.98	3.02	2.99	1.83
PB Ratio	1.19	1.16	1.40	1.51	1.53	0.79
P/FCF Ratio	-	-	-	16.95	-	-
P/OCF Ratio	6.52	5.82	8.22	4.07	6.58	4.28
EV/Sales Ratio	8.39	7.18	7.44	5.59	5.36	4.77
EV/EBITDA Ratio	9.80	9.00	9.03	9.26	9.10	7.53
EV/EBIT Ratio	18.54	16.43	15.97	15.97	14.62	12.92
EV/FCF Ratio	-27.42	-	-	31.37	-	-
Debt / Equity Ratio	1.49	1.70	1.52	1.51	1.35	1.37
Debt / EBITDA Ratio	5.27	5.74	5.21	4.99	4.45	4.99
Debt / FCF Ratio	-	-	-	17.01	-	-
Quick Ratio	0.67	0.60	0.57	0.63	0.57	0.52
Current Ratio	0.72	0.64	0.62	0.71	0.64	0.59
Asset Turnover	0.12	0.13	0.13	0.19	0.21	0.17
Return on Equity (ROE)	8.28%	9.03%	8.17%	7.77%	11.66%	8.95%
Return on Assets (ROA)	3.28%	3.46%	3.74%	4.06%	4.79%	3.99%
Return on Capital (ROIC)	4.02%	3.85%	4.17%	4.54%	5.36%	4.46%
Return on Capital Employed (ROCE)	7.00%	7.70%	8.30%	9.30%	10.20%	8.70%
Earnings Yield	5.54%	6.47%	5.44%	4.26%	6.24%	9.56%
Earnings Yield	5.54%	6.47%	5.44%	4.26%	6.24%	9.56%
FCF Yield	-8.55%	-9.87%	-8.06%	5.90%	-0.09%	-15.10%
Dividend Yield	3.51%	3.91%	4.44%	1.51%	1.09%	2.00%
Payout Ratio	35.51%	30.03%	18.38%	28.60%	12.72%	17.21%
Buyback Yield / Dilution	0.07%	0.25%	-0.22%	-4.06%	-	-
Total Shareholder Return	3.58%	4.15%	4.22%	-2.55%	1.09%	2.00%

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Utility template. Financial Sources.